NCT05769608: A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen
- State
- Completed
- Phase
- Phase 2
- People
- 285 taking part
- Started
- 13 Mar 2023
- Primary completion
- 15 Jan 2025
- Arms
- Dose 1, Dose 2
- Results
- None posted
- 13 Mar 2023: Trial started
- 15 Mar 2023: Trial registered
- 15 Jan 2025: Trial completed